Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

PG UN CL CL Market Drivers Utilities Money Funds 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Processing. Please wait...

KMB insider: Thomas Falk

       

Thomas Falk - KMB Insider Profile

Executive Chairman, CEO and President and Member of Executive Committee

Mr. Thomas J. Falk is Chairman of the Board, Chief Executive Officer of KimberlyClark Corporationrationration. Mr. Falk was elected Chairman of the Board and Chief Executive Officer in 2003 and President and Chief Executive Officer in 2002. Prior to that, he served as President and Chief Operating Officer since 1999. Mr. Falk previously had been elected Group President ? Global Tissue, Pulp and Paper in 1998, where he was responsible for KimberlyClark?s global tissue businesses. Earlier in his career, Mr. Falk had responsibility for KimberlyClark?s North American Infant Care, Child Care and Wet Wipes businesses
Age: 54  Chairman Since 2003      

Other Appointments

KimberlyClark CorporationKMBArgentina Buenos-Aires
Chairman since 2003
SK TELCOM SP ADRKMBGermany Berlin
Chairman since 2003
SK TELCOM SP ADRKMBGermany Frankfurt
Chairman since 2003
SK TELCOM SP ADRKMBGermany Munich
Chairman since 2003
KimberlyClark de MKCDMFUnited States OTC
Chairman since 2010
KimberlyClark de MKCDMYUnited States OTC
Chairman since 2010
KimberlyClark de MKIMBERAMexico Mexico
Chairman since 2010
KimberlyClark de MKCDMFUnited States OTC
Chairman since 2010
KimberlyClark de MKCDMYUnited States OTC
Chairman since 2010
Thomas Falk EducationFalk joined KimberlyClark in 1983 and has held other senior management positions. He was a director of KimberlyClark since 1999. He also serves on the board of directors of Catalyst Inc., the University of Wisconsin Foundation, and the Consumer Goods Forum, and serves as a governor of the Boys & Girls Clubs of America.

Management Efficency

The company has Return on Asset of 10.54 % which means that on every $100 spent on asset it made $10.54 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 35.62 % implying that it generated $35.62 on every 100 dollars invested.
The company has 7.03 B in debt with debt to equity (D/E) ratio of 1.41 which is OK given its current industry classification. KimberlyClark Corporation has Current Ratio of 0.96 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
    

Other Executives

Robert Abernathy, President
Elane Stock, President
Clive Sirkin, President
Karen Leets, President
Paul Alexander, President
Joanne Bauer, President
Jennifer Sepull, President
Michael Hsu, President
Jan Spencer, President
Anthony Palmer, President
Nancy Loewe, President
Christian Brickman, President
Mark Buthman, CFO
Lizanne Gottung, SVP
Thomas Mielke, SVP
Nancy Karch, Director
Fabian Garcia, Director
Robert Decherd, Director
Marc Shapiro, Director
James Jenness, Director
Linda Rice, Director
Mae Jemison, Director
Ian Read, Director
Abelardo Bru, Director
John Alm, Director
John Bergstrom, Director

Entity Summary

KimberlyClark Corporationration, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and health care solutions worldwide. KimberlyClark Corporation [KMB] is traded on New York Stock Exchange in USA. It is located in Dallas, TX and employs 58,000 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
KMB United States NYSE
KimberlyClark Corporation
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
13%
In The Next
Two Years
KimberlyClark Corporation has less than 13.41 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

KMB price boundaries

    
June 05 2013
 96.68 
  
 95.71 
(0.97)  Macroaxis: -1.0033098882912836 Down   1.00%  
Lowest period price (30 days)
May 28 2013
 104.26 
  
 104.53 
0.27  Macroaxis: 0.2589679647036217 Up   0.26%  
Highest period price (30 days)
    

Promote KMB and Thomas Falk

Follow KMB with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add KMB to your reader
 

Today Change

 thisGreen KMB KMB agains markets  0.00 % No Change  
 
 United States Russel   1.35 % Macroaxis: change 1.35 Moved Down  
 
 United States SP 500   1.39 % Macroaxis: change 1.39 Moved Down  
 
 United States NYSE   1.53 % Macroaxis: change 1.53 Moved Down  
 

Stock Performance

Shares Outstanding384.6 M
Number of Shares Shorted8.05 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium